The 7th ESCMID Conference on Vaccines takes place on 22–24 September 2027 at the Lisbon Marriott Hotel, Lisbon, Portugal.
Hosted by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in scientific collaboration with the European Society for Paediatric Infectious Diseases (ESPID), the European Association of Hospital Pharmacists (EAHP) and the European Medicines Agency (EMA), the conference brings together leading experts to explore the latest advances in vaccine science, innovation and global impact.
The programme covers vaccine development and immunology, correlates of protection, real-world evidence, vaccine policy and implementation, paediatric and adult immunisation, vaccine confidence and the role of hospital pharmacy and regulators. Previous editions combined plenary lectures, debates, poster sessions and recorded content; the 2025 edition’s final programme and recordings remain available from ESCMID.
Registration opens on 11 January 2027, with only 400 on-site places. Early registration (until 2 June 2027): ESCMID member EUR 600, non-member EUR 700, Young Scientist member EUR 400, LMIC member EUR 345. Regular registration (from 3 June 2027): member EUR 780, non-member EUR 910, Young Scientist EUR 500, LMIC EUR 445. Registration includes sessions, posters and exhibition, catering and receptions as per programme, and access to online content after the event.
Abstracts: submission opens on 2 March 2027.
The conference is aimed at infectious disease physicians, clinical microbiologists, paediatricians, public-health specialists, hospital pharmacists, vaccine researchers and regulators. A 2027 sponsorship prospectus is available from ESCMID.
